atyr1940
Recombinant proteinexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2014 (NCT02239224)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Histidyl-tRNA synthetaseSupplementation
HARS1 supplementation
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSWS7U5TQ7ZJ ↗
- ChEMBLCHEMBL4297550 ↗
Also known as
- atyr1940
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02836418 | Phase 1/Phase 2 (Phase 2) | Jul 12, 2016 | aTyr Pharma |
| NCT02603562 | Phase 1/Phase 2 (Phase 2) | Mar 30, 2016 | aTyr Pharma |
| NCT02579239 | Phase 1/Phase 2 (Phase 2) | Nov 5, 2015 | aTyr Pharma |
| NCT02531217 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2015 | aTyr Pharma, Sponsor GmbH |
| NCT02239224 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2014 | aTyr Pharma |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| aTyr Pharma | For profit | 5 | 5 | 1 | 2014 |
| Sponsor GmbH | Academic/Hospital | 1 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1